Synthesis and biological evaluation of 99mTc-labetalol for β1-adrenoceptor-mediated cardiac imaging

M. E. Moustapha, M. A. Motaleb, M. H. Sanad

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Abstract

The objective of this work was to set up a method to formulate a complex for the assessment of myocardial infarction in vivo. Labetalol was successfully labeled with 99mTc using SnCl2·2H2O as reducing agent. Various reaction parameters were investigated to optimize the labeling yield. The labeled complex was stable for up to 24 h. The heart uptake was 35.5 % ID/Organ at 5 min post-injection, while the clearance pathways from the body behave via both the hepatobiliary and renal routes.

Original languageEnglish
Pages (from-to)511-516
Number of pages6
JournalJournal of Radioanalytical and Nuclear Chemistry
Volume309
Issue number2
DOIs
StatePublished - 1 Aug 2016

Keywords

  • Tc-labetalol
  • Imaging
  • Myocardial infarction
  • β-adrenoceptor

Fingerprint

Dive into the research topics of 'Synthesis and biological evaluation of 99mTc-labetalol for β1-adrenoceptor-mediated cardiac imaging'. Together they form a unique fingerprint.

Cite this